HLA-A and cancer: To study the impact of accessory receptor ligands on T cell antigen sensitivity, we produced purified Spytag-pMHC by refolding HLA-A*02:01 fused to Spytag with β2m and a peptide from the NY-ESO-1 cancer antigen (Fig. 2A).